Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
Hematologic Oncology Update
00:00
Discussion on the Management of AML and the Continuation of Van Aza
Discussion on the duration of Van Aza treatment, the necessity of continuing antibiotics and antifungals, and the recommendation to reduce treatment days while maintaining ANC stability.
Transcript
Play full episode
